Insufficient scRNA-seq data for expression of RNASE7 at single-cell level.
Insufficient scRNA-seq data for expression of RNASE7 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 33% | 630.43 | 476 / 1445 | 62% | 25.50 | 114 / 183 |
tonsil | 0% | 0 | 0 / 0 | 84% | 16.46 | 38 / 45 |
skin | 73% | 510.35 | 1326 / 1809 | 11% | 2.16 | 51 / 472 |
pancreas | 21% | 7.54 | 70 / 328 | 60% | 3.27 | 107 / 178 |
bladder | 29% | 10.62 | 6 / 21 | 51% | 7.79 | 259 / 504 |
prostate | 55% | 27.16 | 134 / 245 | 22% | 0.39 | 110 / 502 |
breast | 48% | 51.43 | 222 / 459 | 24% | 0.79 | 266 / 1118 |
liver | 35% | 14.17 | 79 / 226 | 29% | 1.86 | 117 / 406 |
uterus | 3% | 6.13 | 5 / 170 | 60% | 14.24 | 275 / 459 |
lung | 5% | 1.46 | 30 / 578 | 36% | 6.62 | 413 / 1155 |
intestine | 2% | 0.70 | 21 / 966 | 22% | 1.50 | 114 / 527 |
stomach | 1% | 1.75 | 3 / 359 | 17% | 0.41 | 48 / 286 |
spleen | 17% | 5.20 | 40 / 241 | 0% | 0 | 0 / 0 |
thymus | 1% | 0.30 | 8 / 653 | 14% | 1.46 | 83 / 605 |
muscle | 14% | 7.00 | 109 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 10% | 3.26 | 26 / 258 | 3% | 0.04 | 7 / 230 |
kidney | 4% | 1.17 | 4 / 89 | 3% | 0.06 | 23 / 901 |
adipose | 7% | 2.42 | 81 / 1204 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 4% | 0.11 | 18 / 430 |
blood vessel | 1% | 0.66 | 15 / 1335 | 0% | 0 | 0 / 0 |
brain | 0% | 0.14 | 12 / 2642 | 0% | 0.00 | 3 / 705 |
peripheral blood | 0% | 0.11 | 3 / 929 | 0% | 0 | 0 / 0 |
heart | 0% | 0.08 | 2 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050829 | Biological process | defense response to Gram-negative bacterium |
GO_0051715 | Biological process | cytolysis in another organism |
GO_0061844 | Biological process | antimicrobial humoral immune response mediated by antimicrobial peptide |
GO_0050832 | Biological process | defense response to fungus |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0019731 | Biological process | antibacterial humoral response |
GO_0045087 | Biological process | innate immune response |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0005737 | Cellular component | cytoplasm |
GO_0042834 | Molecular function | peptidoglycan binding |
GO_0001530 | Molecular function | lipopolysaccharide binding |
GO_0004540 | Molecular function | RNA nuclease activity |
GO_0004519 | Molecular function | endonuclease activity |
GO_0003676 | Molecular function | nucleic acid binding |
Gene name | RNASE7 |
Protein name | Ribonuclease 7 (RNase 7) (EC 3.1.27.-) (Skin-derived antimicrobial protein 2) (SAP-2) |
Synonyms | UNQ2516/PRO6006 |
Description | FUNCTION: Exhibits a potent RNase activity . Has broad-spectrum antimicrobial activity against many pathogenic microorganisms including uropathogenic E.coli (UPEC), and remarkably potent activity (lethal dose of 90% < 30 nM) against a vancomycin resistant Enterococcus faecium . Causes loss of bacterial membrane integrity . Probably contributes to urinary tract sterility . Bactericidal activity is independent of RNase activity . . |
Accessions | Q9H1E1 ENST00000298690.5 ENST00000481538.1 |